Cargando...

BIOMARKERS TO DETECT CENTRAL DOPAMINE DEFICIENCY AND DISTINGUISH PARKINSON DISEASE FROM MULTIPLE SYSTEM ATROPHY

OBJECTIVE: Biomarkers are increasingly important to diagnose and test treatments of neurodegenerative diseases such as Parkinson disease (PD). This study compared neuroimaging, neurochemical, and olfactory potential biomarkers to detect central dopamine (DA) deficiency and distinguish PD from multip...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goldstein, David S., Holmes, Courtney, Bentho, Oladi, Sato, Takuya, Moak, Jeffrey, Sharabi, Yehonatan, Imrich, Richard, Conant, Shielah, Eldadah, Basil A.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650101/
https://ncbi.nlm.nih.gov/pubmed/18325818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2008.01.010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!